ACQUIRED · 2022
Who Acquired LDPath Limited?
SourceBio International · $24.2M· 46.3× EBITDA
The acquisition
LDPath Limited was acquired by SourceBio International in 2022 for $24.2M. The deal was priced at 46.3× EBITDA / 4.00× revenue.
LDPath Limited at time of acquisition
Revenue
$6.0M
EBITDA
$0.5M
Deal value
$24.2M
EV / EBITDA
46.3×
Similar healthcare it acquisitions
- Eucalyptus · acquired by Hims & Hers Health, Inc. in 2026 · $1.15B
- Gleamer SAS · acquired by RadNet, Inc. in 2026 · $251.6M
- HealthEZ · acquired by Blue Cross Blue Shield of New Jersey in 2026 · $360.0M
- Unbound Medicine · acquired by MPS Ltd in 2026 · $16.5M
- AccessOne · acquired by Phreesia, Inc. in 2025 · $160.0M
Run a valuation for a similar healthcare it business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the healthcare it calculator →More on healthcare it valuations
- Healthcare It valuation calculator· head-term variant
- Healthcare It median multiples· real-deal benchmarks
- How to value a healthcare it· long-form guide
Sourced from Press releases. Full deal page.
Citation: ExitValue.ai. (2022). LDPath Limited acquired by SourceBio International. https://exitvalue.ai/acquired/ldpath-limited